Criminal Code Regulations 2002 (Cth)

Criminal Code Regulations 2002

Statutory Rules No. 67, 2002

made under the

Criminal Code Act 1995

Compilation No. 54

Compilation date: 18 November 2017

Includes amendments up to: F2017L01490

Registered: 20 November 2017

About this compilation

This compilation

This is a compilation of the Criminal Code Regulations 2002 that shows the text of the law as amended and in force on 18 November 2017 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register ( The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents

Part 1Preliminary 1Name of Regulations

These Regulations are the Criminal Code Regulations 2002.

3Definitions

In these Regulations:
AFP member has the same meaning as in Part 5.3 of the Code.
authorised person means a person authorised in writing by the Health Secretary to be an authorised person for the purposes of regulation 5 of the Customs (Prohibited Imports) Regulations 1956.
chief executive officer of a legal aid commission of a State or Territory means the person holding, or performing the duties of, the following position:
(a)
for New South Wales, Queensland and the Australian Capital Territory—Chief Executive Officer of the legal aid commission of that State or Territory;
(b)
for Victoria—managing director of the board of directors of Victoria Legal Aid under the Legal Aid Act 1978 (Vic);
(c)
for Western Australia—Director of Legal Aid under the Legal Aid Commission Act 1976 (WA);
(d)
for South Australia—Director of Legal Services under the Legal Services Commission Act 1977 (SA);
(e)
for Tasmania—Director of the Commission under the Legal Aid Commission Act 1990 (Tas.);
(f)
for the Northern Territory—Director of Legal Aid under the Legal Aid Act (NT).
Code means the Criminal Code.
control order has the same meaning as in Part 5.3 of the Code.
Health Department means the Department administered by the Health Minister.
Health Minister means the Minister administering the Therapeutic Goods Act 1989.
Health Secretary means the Secretary to the Health Department.
issuing court has the same meaning as in Part 5.3 of the Code.
lawyer has the same meaning as in Part 5.3 of the Code.
legal aid commission means an authority established by or under a law of a State or Territory for the purpose of providing legal assistance.
mental impairment has a meaning affected by subsections 7.3(8) and (9) of the Code.
parent has a meaning affected by the Dictionary at the end of the Code.

Part 2Security of the CommonwealthDivision 1Control orders3ALegal representation for young people

For the purposes of subsection 104.28(6) of the Code, this Division provides in relation to the appointing of a lawyer for a person who is at least 14 but under 18 (the young person) to act for the young person in relation to proceedings relating to a control order.

3BCourt may request legal aid commission to arrange representation

An issuing court may request a legal aid commission (the relevant legal aid commission) to arrange the legal representation of the young person.

3CAFP to inform relevant persons of request and contact details

(1)
This regulation applies if the issuing court decides to make a request under regulation 3B.
Informing the legal aid commission
(2)
An AFP member, or a legal representative of the Australian Federal Police, must:
(a)
in writing, inform the chief executive officer of the relevant legal aid commission of the request; and
(b)
give the relevant legal aid commission the following information (if any) that the AFP member or legal representative has:
(i)
the young person’s name;
(ii)
the young person’s residential address;
(iii)
the young person’s contact details, including a telephone number and an email address;
(iv)
the young person’s date of birth;
(v)
the name, residential address and contact details of at least one parent or guardian of the young person;
(vi)
if the young person requires assistance with communication—information about the assistance required.
Note: For subparagraph (b)(vi), a person may need assistance with communication because, for example, the young person is deaf or hearing impaired, is unable to read, has a mental impairment, or requires an interpreter.
Informing the young person
(3)
An AFP member must:
(a)
inform the young person of the request; and
(b)
give the young person sufficient information about the relevant legal aid commission to enable the young person to contact and, if necessary, attend the legal aid commission, including the following information (if any) that the AFP member has:
(i)
the name of the legal aid commission;
(ii)
the legal aid commission’s business address (not being a post box);
(iii)
the legal aid commission’s contact details, including a telephone number and an email address;
(iv)
any other information about the legal aid commission provided by the issuing court; and
(c)
ensure that the young person understands the information provided to them under paragraphs (a) and (b) (taking into account the person’s age, language skills, mental capacity and any other relevant factor).
(4)
Subregulation (3) does not apply if the actions of the young person make it impracticable for the AFP member to comply with that subregulation.
Informing a parent or guardian of the young person
(5)
An AFP member must take reasonable steps to:
(a)
inform at least one parent or guardian of the young person of the request; and
(b)
give the parent or guardian the relevant legal aid commission’s contact details (including the details mentioned in paragraph (3)(b)).
(6)
The AFP member or legal representative complying with subregulation (2), (3) or (5) must do so as soon as practicable after the issuing court decides to make the request and at least 48 hours before the next day when the court will conduct proceedings relating to the control order.

Division 2Preventative detention orders4Preventative detention orders – corresponding State preventative detention law

(1)
For the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, a law of a State or Territory that is set out in Part 1 of Schedule 1 is declared to correspond to Division 105 of the Code.
(2)
For the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, particular provisions of a law of a State or Territory that are set out in Part 2 of Schedule 1 are declared to correspond to Division 105 of the Code.

4AContinuing detention order proceedings – matters court may take into account in determining whether circumstances beyond offender’s control

For the purposes of paragraph 105A.15A(3)(a) of the Code, the following matters are prescribed as matters that a Supreme Court of a State or Territory may take into account in determining whether circumstances are beyond an offender’s control in relation to a continuing detention order proceeding:
(a)
an offender’s financial circumstances;
(b)
whether an offender has engaged in unreasonable conduct during the proceeding that has contributed to the offender’s inability to afford any or all of the costs and expenses of obtaining legal representation for the proceeding;
(c)
both of the following:
(i)
whether an offender has made any efforts to obtain legal aid or legal assistance;
(ii)
the outcomes of any such efforts;
(d)
any other matter that the Court considers relevant.

4BContinuing detention orders – sharing information

The following persons are prescribed for the purposes of subsections 105A.19(1) and (3) of the Code:
(a)
a senior executive AFP employee or an AFP employee who is acting as, or performing the duties of, a senior executive AFP employee (all within the meaning of the Australian Federal Police Act 1979);
(b)
a member of the police force or police service of a State or Territory;
(c)
an officer or employee of a State or Territory, or of an authority of a State or Territory, whose duties relate to corrective services (including prison medical, psychological and psychiatric services), justice or parole;
(d)
a person who provides services for, or on behalf of:
(i)
a State or Territory; or
(ii)
an authority of a State or Territory;
in relation to corrective services (including prison medical, psychological and psychiatric services), justice or parole;
(e)
the Director of Public Prosecutions or a person performing a similar function under a law of a State or Territory;
(f)
a member of the staff of the Office of the Director of Public Prosecutions (within the meaning of the Director of Public Prosecutions Act 1983) or of a similar body established under a law of a State or Territory;
(g)
the Director‑General of the Australian Security Intelligence Organisation, a Deputy Director‑General of the Australian Security Intelligence Organisation, an ASIO employee or an ASIO affiliate (all within the meaning of the Australian Security Intelligence Organisation Act 1979);
(h)
an employee of a Department administered by the Minister responsible for administering:
(i)
the Migration Act 1958; or
(ii)
the Australian Citizenship Act 2007.

Part 3Dangers to the communityDivision 1Cross‑border firearms trafficking5Cross‑border firearms trafficking

For the definition of firearm law in subsections 360.2(3) and 360.3(2) of the Code, the Acts, and any regulations made under those Acts, mentioned in Schedule 2 are prescribed.

Division 2Serious drugs and precursors5AControlled drugs

(1)
For paragraph 301.1(1)(a) of the Code, a drug listed in column 1 of an item in Schedule 3 is a controlled drug.
(2)
For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in Schedule 3 is the commercial quantity of the controlled drug listed in column 1 of that item.
(3)
For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in Schedule 3 is the marketable quantity of the controlled drug listed in column 1 of that item.
(4)
For paragraph (a) of item 1 of the table in section 301.12 of the Code, the quantity listed in column 4 of an item in Schedule 3 is the trafficable quantity of the controlled drug listed in column 1 of that item.

5BControlled plants

(1)
For paragraph 301.2(1)(a) of the Code, a growing plant listed in column 1 of an item in the following table is a controlled plant.

Controlled plants and quantities
Item	Column 1	Column 2	Column 3	Column 4
Controlled plant	Commercial quantity	Marketable quantity	Trafficable quantity
1	Any plant of the genus Cannabis	250 kg or 1,000 plants	25 kg or 100 plants	250 g or 10 plants

(2)
For paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity listed in column 2 of an item in the table in subregulation (1) is a commercial quantity of the controlled plant listed in column 1 of that item.
(3)
For paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity listed in column 3 of an item in the table in subregulation (1) is a marketable quantity of the controlled plant listed in column 1 of that item.
(4)
For paragraph (a) of item 1 of the table in section 301.12 of the Code, a quantity listed in column 4 of an item in the table in subregulation (1) is the trafficable quantity of the controlled plant listed in column 1 of that item.

5CControlled precursors

(1)
For paragraph 301.3(1)(a) of the Code, a precursor listed in column 1 of an item in the following table is a controlled precursor.

Controlled precursors and quantities
Item	Column 1	Column 2	Column 3
Controlled precursor	Commercial quantity (kilograms)	Marketable quantity (grams)
1	Ephedrine	1.2	400.0
2	Ergometrine	0.006	0.15
3	Ergotamine	0.01	0.25
4	Isosafrole	1.45	290.0
5	Lysergic acid	0.003	0.075
6	3,4‑Methylenedioxyphenylacetic acid	1.5	300.0
7	3,4‑Methylenedioxyphenyl‑2‑propanone	0.75	150.0
8	Phenylacetic acid	4.05	1,350.0
9	Phenylpropanolamine	1.2	400.0
10	Phenyl‑2‑propanone	2.03	675.0
11	Piperonal	1.6	320.0
12	Pseudoephedrine	1.2	400.0
13	Safrole	2.85	570.0

Note: A salt or ester of a precursor listed in column 1 of the table is also a controlled precursor: see paragraph 301.3(b) of the Code.
(2)
For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in the table in subregulation (1) is the commercial quantity of the controlled precursor listed in column 1 of that item.
(3)
For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in the table in subregulation (1) is the marketable quantity of the controlled precursor listed in column 1 of that item.

5DBorder controlled drugs

(1)
For paragraph 301.4(a) of the Code, a drug listed in column 1 of an item in Schedule 4 is a border controlled drug.
(2)
For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in Schedule 4 is the commercial quantity of the border controlled drug listed in column 1 of that item.
(3)
For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in Schedule 4 is the marketable quantity of the border controlled drug listed in column 1 of that item.

5EBorder controlled plants

(1)
For paragraph 301.5(a) of the Code, a growing plant listed in column 1 of an item in the following table is a border controlled plant.

Border controlled plants and quantities
Item	Column 1	Column 2	Column 3
Border controlled plant	Commercial quantity	Marketable quantity
1	Any plant of the genus Cannabis	250 kg or 1,000 plants	25 kg or 100 plants
2	Any plant of the genus Erythroxylon (also known as Erythroxylum) from which cocaine can be extracted either directly or by chemical transformation	80 kg
3	Any plant of the genus Lophophora
4	Any plant of the species Papaver bracteatum	10 kg
5	Any plant of the species Papaver somniferum	10 kg
6	Any plant of the species Piptagenia peregrine
7	Any plant of the species Psilocybe

(2)
For paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity (if any) listed in column 2 of an item in the table in subregulation (1) is a commercial quantity of the border controlled plant listed in column 1 of that item.
(3)
For paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity (if any) listed in column 3 of an item in the table in subregulation (1) is a marketable quantity of the border controlled plant listed in column 1 of that item.

5FBorder controlled precursors

(1)
For paragraph 301.6(1)(a) of the Code, a precursor listed in column 1 of an item in the following table is a border controlled precursor.

Border controlled precursors and quantities
Item	Column 1	Column 2	Column 3
Border controlled precursor	Commercial quantity (kilograms)	Marketable quantity (grams)
1	N‑Acetylanthranilic acid
2	Any plant of the species Ephedra
3	Ephedrine	1.2	3.2
4	Ergometrine	0.006	0.006
5	Ergotamine	0.01	0.01
6	Isosafrole	1.45	1.45
7	Lysergic acid	0.003	0.003
8	3,4‑Methylenedioxyphenyl‑2‑propanone	0.75	0.75
9	Phenylacetic acid	4.05	10.8
10	Phenylpropanolamine	1.2	3.2
11	Phenyl‑2‑propanone	2.03	5.4
12	Piperonal	1.6	1.6
13	Pseudoephedrine	1.2	3.2
14	Safrole	2.85	2.85

Note: A salt or ester of a precursor listed in column 1 of the table and an immediate precursor of a precursor listed in column 1 of the table is a border controlled precursor: see paragraphs 301.6(1)(b) and (c) of the Code.
(2)
For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity (if any) listed in column 2 of an item in the table in subregulation (1) is the commercial quantity of the border controlled precursor listed in column 1 of that item.
(3)
For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) listed in column 3 of an item in the table in subregulation (1) is the marketable quantity of the border controlled precursor listed in column 1 of that item.

Division 3Psychoactive substances5GImporting psychoactive substances

(1)
For paragraph 320.2(2)(l) of the Code, a substance that is imported into Australia in accordance with the conditions set out in subregulation (2) is prescribed.
(2)
For the purpose of subregulation (1), the conditions are that:
(a)
the person importing the substance (the importer) is the holder of a licence to import drugs granted by the Health Secretary or an authorised person under subregulation 5(5) of the Customs (Prohibited Imports) Regulations 1956; and
(b)
the importer:
(i)
is, or is employed by, a forensic laboratory and is importing the substance for the purposes of forensic analysis; or
(ii)
is the Australian Federal Police, or a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or
(iii)
is the Commissioner or a Deputy Commissioner of the Australian Federal Police, or is the head or deputy head (however described) of a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or
(iv)
is, or is employed by, a medical research facility and is importing the substance for the purposes of medical research; or
(v)
is, or is employed by, a scientific research facility and is importing the substance for the purposes of scientific research; or
(vi)
is, or is employed by, an entity that imports drugs on behalf of a person or body mentioned in subparagraph (i), (ii), (iii), (iv) or (v), being a person or body that also holds a licence of a kind mentioned in paragraph (a), and is importing the substance at the written request of the person or body; and
(c)
before the substance is imported, the importer gives the Health Secretary or an authorised person a written notice about the proposed importation that includes:
(i)
the identity and amount of the substance being imported; and
(ii)
the purpose of the importation; and
(iii)
a 30‑day period during which the importation is likely to occur; and
(iv)
the importer’s name and import licence number; and
(v)
if subparagraph (b)(i), (iv), (v) or (vi) applies and the importer is employed by the body mentioned in the applicable subparagraph—the name of the importer’s employer; and
(vi)
any other information required by the Health Secretary.
(3)
For the purpose of paragraph (2)(c), the Health Secretary may determine:
(a)
information to be included in a notice; and
(b)
the way a notice may be given to the Health Secretary or an authorised person.
(4)
In this regulation:
drug has the same meaning as in subregulation 5(20) of the Customs (Prohibited Imports) Regulations 1956.

5HImporting substances represented to be serious drug alternatives

(1)
For paragraph 320.3(3)(f) of the Code, a substance that is imported into Australia in accordance with the conditions set out in subregulation (2) is prescribed.
(2)
For the purpose of subregulation (1), the conditions are that:

(a)
the person importing the substance (the importer) is the holder of a licence to import drugs granted by the Health Secretary or an authorised person under subregulation 5(5) of the Customs (Prohibited Imports) Regulations 1956; and
(b)
the importer:
(i)
is, or is employed by, a forensic laboratory and is importing the substance for the purposes of forensic analysis; or
(ii)
is the Australian Federal Police, or a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or
(iii)
is the Commissioner or a Deputy Commissioner of the Australian Federal Police, or is the head or deputy head (however described) of a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or
(iv)
is, or is employed by, a medical research facility and is importing the substance for the purposes of medical research; or
(v)
is, or is employed by, a scientific research facility and is importing the substance for the purposes of scientific research; or
(vi)
is, or is employed by, an entity that imports drugs on behalf of a person or body mentioned in subparagraph (i), (ii), (iii), (iv) or (v), being a person or body that also holds a licence of a kind mentioned in paragraph (a), and is importing the substance at the written request of the person or body; and
(c)
before the substance is imported, the importer gives the Health Secretary or an authorised person a written notice about the proposed importation that includes:
(i)
the identity and amount of the substance being imported; and
(ii)
the purpose of the importation; and
(iii)
a 30‑day period during which the importation is likely to occur; and
(iv)
the importer’s name and import licence number; and
(v)
if subparagraph (b)(i), (iv), (v) or (vi) applies and the importer is employed by the body mentioned in the applicable subparagraph—the name of the importer’s employer; and
(vi)
any other information required by the Health Secretary.
(3)
For the purpose of paragraph (2)(c), the Health Secretary may determine:
(a)
information to be included in a notice; and
(b)
the way a notice may be given to the Health Secretary or an authorised person.
(4)
In this regulation:
drug has the same meaning as in subregulation 5(20) of the Customs (Prohibited Imports) Regulations 1956.

Part 4National infrastructure 6Dangerous goods

For subparagraph 471.15(1)(b)(ii) of the Code, the following substances and things must not, without exception, be carried by post:
(a)
gas that is so toxic or corrosive to humans as to pose a hazard to health;
(b)
a thermally unstable substance that is likely to undergo a strongly exothermic decomposition;
(c)
a substance that ignites or self‑heats when in contact with air.

Part 5Application and transitional provisions 7Application of the Criminal Code Amendment (Control Orders – Legal Representation for Young People) Regulations 2017

(1)
The amendments made by items 1 and 2 of Schedule 1 to the Criminal Code Amendment (Control Orders—Legal Representation for Young People) Regulations 2017 apply in relation to the parts of a proceeding that occur after the commencement of that instrument if:
(a)
the proceeding commenced before or after the commencement of that instrument; and
(b)
the proceeding relates to a control order made on or after 30 November 2016; and
(c)
the control order was, or is, requested (however described) on or after 30 November 2016.
(2)
To avoid doubt, those amendments apply in accordance with subregulation (1) regardless of when the conduct to which that request relates occurred or occurs.
Note: The conduct may have occurred before or after 30 November 2016.

Schedule 1Corresponding State preventative detention law

(regulation 4)

Part 1Laws of a State or Territory

Item	Declared laws
1	Terrorism (Preventative Detention) Act 2005 (Qld)
1A	Terrorism (Preventative Detention) Act 2006 (WA)
2	Terrorism (Preventative Detention) Act 2005 (SA)
3	Terrorism (Preventative Detention) Act 2005 (Tas)

Part 2Particular provisions of a law of a State or Territory

Item	Declared provisions
1	Part 2A, Terrorism (Police Powers) Act 2002 (NSW)
2	Part 2A, Terrorism (Community Protection) Act 2003 (Vic)
3	Part 2, Terrorism (Extraordinary Temporary Powers) Act 2006 (ACT)
4	Part 2B, Terrorism (Emergency Powers) Act (NT)

Schedule 2Cross‑border firearms trafficking

(regulation 5)

Item	Act
1	Firearms Act 1996 (NSW)
2	Firearms Act 1996 (Vic)
3	Weapons Act 1990 (Qld)
4	Firearms Act 1973 (WA)
5	Firearms Act 1977 (SA)
6	Firearms Act 1996 (Tas)
7	Firearms Act 1996 (ACT)
8	Firearms Act 1997 (NT)
9	Firearms Act 1997 (Norfolk Island)

Schedule 3Controlled drugs

Note: See regulation 5A.

Controlled drugs and quantities
Item	Column 1	Column 2	Column 3	Column 4
Controlled drug	Commercial quantity (kilograms)	Marketable quantity (grams)	Trafficable quantity (grams)
1	Acetorphine	2.0	250.0	2.0
2	Acetyl‑alpha‑methylfentanyl	0.005	2.5	0.005
3	4‑Acetoxy‑N, N‑dimethyltryptamine (4‑AcO‑DMT)	2.0	250.0	2.0
4	4‑Acetoxy‑N‑methyl‑N‑ethyltryptamine (4‑AcO‑MET)	2.0	250.0	2.0
5	Acetylcodeine	2.0	250.0	2.0
6	Acetyldihydrocodeine	2.0	250.0	2.0
7	Acetylmethadol	2.0	250.0	2.0
8	Allylprodine	2.0	250.0	2.0
9	Alphacetylmethadol	10.0	5,000.0	10.0
10	Alphameprodine	0.2	100.0	0.2
11	Alphamethadol	0.2	100.0	0.2
12	alpha‑Methylfentanyl	0.005	2.5	0.005
13	alpha‑Methylthiofentanyl	0.005	2.5	0.005
14	alpha‑Pyrrolidinobutiophenone (α‑PBP)	0.75	250.0	0.75
15	alpha‑Pyrrolidinopropiophenone (α‑PPP)	0.75	250.0	0.75
16	alpha‑Pyrrolidinovalerophenone (α‑PVP)	0.75	250.0	0.75
17	Alphaprodine	25.0	12,500.0	25.0
18	5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)	0.75	250.0	0.75
19	6‑(2‑Aminopropyl)‑2,3‑dihydrobenzofuran (6‑APDB)	0.75	250.0	0.75
20	Amphetamine	0.75	250.0	2.0
21	Anileridine	25.0	12,500.0	25.0
22	Barbiturates	5.0	5.0
23	Benzethidine	10.0	5,000.0	10.0
24	1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)	0.75	250.0	0.75
25	Benzoylecgonine	2.0	250.0	2.0
26	Benzylmorphine	5.0	2,500.0	5.0
27	Benzylpiperazine	0.75	250.0	2.0
28	Betacetylmethadol	5.0	2,500.0	5.0
29	beta‑Hydroxyfentanyl	0.005	2.5	0.005
30	beta‑Hydroxy‑3‑methylfentanyl	0.005	2.5	0.005
31	beta‑Keto‑methylbenzodioxolylpentanamine (pentylone)	0.75	250.0	0.75
32	beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone)	0.75	250.0	0.75
33	Betameprodine	5.0	2,500.0	5.0
34	Betamethadol	5.0	2,500.0	5.0
35	Betaprodine	5.0	2,500.0	5.0
36	Bezitramide	5.0	2,500.0	5.0
37	2‑Bromoamphetamine	0.75	250.0	0.75
38	3‑Bromoamphetamine	0.75	250.0	0.75
39	4‑Bromoamphetamine	0.75	250.0	0.75
40	4‑Bromo‑2,5‑dimethoxyamphetamine	0.5	100.0	0.5
41	2‑Bromo‑5‑methoxymethcathinone	0.75	250.0	0.75
42	2‑Bromomethamphetamine	0.75	250.0	0.75
43	3‑Bromomethamphetamine	0.75	250.0	0.75
44	4‑Bromomethamphetamine	0.75	250.0	0.75
45	2‑Bromomethcathinone	0.75	250.0	0.75
46	3‑Bromomethcathinone	0.75	250.0	0.75
47	4‑Bromomethcathinone	0.75	250.0	0.75
48	Bufotenine	2.0	250.0	2.0
49	Bupropion	0.75	250.0	0.75
50	Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	125.0	25,000.0	250.0
51	Cannabis resin	125.0	25,000.0	20.0
52	Cathinone	0.75	250.0	0.75
53	1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C)	0.5	100.0	0.5
54	2‑Chloroamphetamine	0.75	250.0	0.75
55	3‑Chloroamphetamine	0.75	250.0	0.75
56	4‑Chloroamphetamine	0.75	250.0	0.75
57	2‑Chloromethamphetamine	0.75	250.0	0.75
58	3‑Chloromethamphetamine	0.75	250.0	0.75
59	4‑Chloromethamphetamine	0.75	250.0	0.75
60	4‑Chloro‑N‑ethylamphetamine	0.75	250.0	0.75
61	2‑Chloromethcathinone	0.75	250.0	0.75
62	3‑Chloromethcathinone	0.75	250.0	0.75
63	4‑Chloromethcathinone	0.75	250.0	0.75
64	4‑Chlorophenyl‑1‑methoxypropan‑2‑amine	0.75	250.0	0.75
65	Chlorphentermine	2.0	250.0	2.0
66	Clonitazene	5.0	100.0	5.0
67	Cocaine	2.0	250.0	2.0
68	Codeine	10.0	5,000.0	10.0
69	Codeine‑N‑oxide	10.0	5,000.0	10.0
70	Codoxime	10.0	5,000.0	10.0
71	Desomorphine	2.0	250.0	2.0
72	Dexamphetamine	2.0	250.0	2.0
73	Dextromoramide	2.0	250.0	2.0
74	Diampromide	5.0	2,500.0	5.0
75	Diethylpropion (N, N‑Diethylcathinone)	5.0	2,500.0	5.0
76	Diethylthiambutene	5.0	2,500.0	5.0
77	N,N‑Diethyltryptamine	2.0	250.0	2.0
78	Difenoxin	2.0	250.0	2.0
79	1‑(2,3‑Dihydro‑1‑benzofuran‑5‑yl)propan‑2‑amine (5‑APDB)	0.75	250.0	0.75
80	Dihydrocodeine	10.0	5,000.0	10.0
81	Dihydromorphine	10.0	5,000.0	10.0
82	Dimenoxadol	10.0	5,000.0	10.0
83	Dimepheptanol	10.0	5,000.0	10.0
84	2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)	0.5	100.0	0.5
85	2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)	0.5	100.0	0.5
86	2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)	0.5	100.0	0.5
87	2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)	0.75	250	0.75
88	2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)	0.5	100.0	0.5
89	2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)	0.5	100.0	0.5
90	2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)	0.5	100.0	0.5
91	3,4‑Dimethoxymethcathinone	0.75	250.0	0.75
92	1‑Dimethylamino‑1,2‑diphenylethane	5.0	2,500.0	5.0
93	N,N‑Dimethylamphetamine	0.75	250.0	0.75
94	N, N‑Dimethylcathinone	0.75	250.0	0.75
95	1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210)	5.0	1,000.0	5.0
96	3,4‑Dimethylmethcathinone	0.75	250.0	0.75
97	Dimethylthiambutene	20.0	10,000.0	20.0
98	N,N‑Dimethyltryptamine	2.0	250.0	2.0
99	Dioxaphetyl butyrate	2.0	250.0	2.0
100	Diphenoxylate	2.0	250.0	2.0
101	Dipipanone	10.0	5,000.0	10.0
102	Drotebanol	2.0	250.0	2.0
103	Ecgonine	10.0	5,000.0	10.0
104	Ethchlorvynol	50.0	50.0
105	Ethinamate	50.0	50.0
106	N‑Ethylcathinone	0.75	250.0	0.75
107	Ethylmethylthiambutene	10.0	5,000.0	10.0
108	Ethylmorphine	2.0	250.0	2.0
109	3‑(2‑Ethylphenyl)‑2‑methyl‑quinazolin‑4‑one (Etaqualone)	5.0	5.0
110	Etonitazene	5.0	2,500.0	5.0
111	Etorphine	5.0	2,500.0	5.0
112	Etoxeridine	5.0	2,500.0	5.0
113	Fentanyl	0.005	2.5	0.005
114	4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)	0.5	100.0	0.5
115	2‑Fluoroamphetamine	0.75	250.0	0.75
116	3‑Fluoroamphetamine	0.75	250.0	0.75
117	4‑Fluoroamphetamine	0.75	250.0	0.75
118	2‑Fluoromethamphetamine	0.75	250.0	0.75
119	3‑Fluoromethamphetamine	0.75	250.0	0.75
120	4‑Fluoromethamphetamine	0.75	250.0	0.75
121	2‑Fluoromethcathinone	0.75	250.0	0.75
122	3‑Fluoromethcathinone	0.75	250.0	0.75
123	4‑Fluoromethcathinone	0.75	250.0	0.75
124	Furethidine	1.0	500.0	1.0
125	Gammabutyrolactone (GBL)	1.0	250.0	0.5
126	Glutethimide	50.0	50.0
127	Heroin (diacetylmorphine)	1.5	250.0	2.0
128	Hydrocodone	2.0	250.0	2.0
129	Hydromorphinol	2.0	250.0	2.0
130	Hydromorphone	2.0	250.0	2.0
131	Hydroxyamphetamine	2.0	250.0	2.0
132	4‑Hydroxybutanoic acid (GHB)	1.0	250.0	0.5
133	p‑Hydroxyephedrine	2.0	250.0	2.0
134	Hydroxypethidine	0.75	250.0	0.75
135	2‑Iodoamphetamine	0.75	250.0	0.75
136	3‑Iodoamphetamine	0.75	250.0	0.75
137	4‑Iodoamphetamine	0.75	250.0	0.75
138	2‑Iodomethamphetamine	0.75	250.0	0.75
139	3‑Iodomethamphetamine	0.75	250.0	0.75
140	4‑Iodomethamphetamine	0.75	250.0	0.75
141	2‑Iodomethcathinone	0.75	250.0	0.75
142	3‑Iodomethcathinone	0.75	250.0	0.75
143	4‑Iodomethcathinone	0.75	250.0	0.75
144	Isomethadone	2.0	250.0	2.0
145	4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)	0.5	100.0	0.5
146	Ketamine	1.0	500.0	3.0
147	Ketobemidone	2.0	250.0	2.0
148	Levophenacylmorphan	2.0	250.0	2.0
149	Levomethorphan	2.0	250.0	2.0
150	Levorphanol, but not including dextrorphan	1.0	500.0	1.0
151	Lysergamides	0.01	0.01
152	Lysergide (LSD)	0.002	0.05	0.002
153	Meprobamate	50.0	50.0
154	Mescaline	7.5	3.75	7.5
155	Metazocine	7.0	3,500.0	7.0
156	Methadone	2.0	250.0	2.0
157	Methamphetamine	0.75	250.0	2.0
158	Methaqualone	5.0	5.0
159	Methcathinone	0.75	250.0	2.0
160	Methorphan, but not including dextromethorphan	2.0	250.0	2.0
161	4’‑Methoxy‑alpha‑pyrrolidinopropiophenone (MOPPP)	0.75	250.0	0.75
162	4‑Methoxyamphetamine	0.75	250.0	0.75
163	4‑Methoxymethamphetamine	0.75	250.0	0.75
164	4‑Methoxymethcathinone	0.75	250.0	0.75
165	4’‑Methyl‑alpha‑pyrrolidinobutiophenone (MPBP)	0.75	250.0	0.75
166	4’‑Methyl‑alpha‑pyrrolidinohexiophenone (MPHP)	0.75	250.0	0.75
167	4’‑Methyl‑alpha‑pyrrolidinopropiophenone (MPPP)	0.75	250.0	0.75
168	N‑Methyl butylone	0.75	250.0	0.75
169	2‑Methylamino‑1‑phenylbutan‑1‑ one (buphedrone)	0.75	250.0	0.75
170	4‑Methylamphetamine	0.75	250.0	0.75
171	3,4‑Methylenedioxyamphetamine (MDA)	0.75	100.0	0.5
172	4‑Methylethcathinone	0.75	250.0	0.75
173	3,4‑Methylenedioxymethamphetamine (MDMA)	0.5	100.0	0.5
174	Methyldesorphine	2.0	250.0	2.0
175	Methyldihydromorphine	2.0	250.0	2.0
176	3,4‑Methylenedioxyethcathinone (MDEC)	0.75	250.0	0.75
177	3,4‑Methylenedioxymethcathinone (MDMC)	0.75	250.0	0.75
178	3,4‑Methylenedioxypyrovalerone (MDPV)	0.75	250.0	0.75
179	3’,4’‑Methylenedioxy‑alpha‑pyrrolidinobutiophenone (MDPBP)	0.75	250.0	0.75
180	3’,4’‑Methylenedioxy‑alpha‑pyrrolidinopropiophenone (MDPPP)	0.75	250.0	0.75
181	3‑Methylfentanyl	0.005	2.5	0.005
182	4‑Methylmethamphetamine	0.75	250.0	0.75
183	4‑Methylmethcathinone (4‑MMC)	0.75	250.0	2.0
184	Methylphenidate	2.0	250.0	2.0
185	1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)	2.0	250.0	2.0
186	4‑Methylthioamphetamine (4‑MTA)	0.75	250.0	0.75
187	4‑Methylthiobutylamphetamine (4‑MTBA)	0.75	250.0	0.75
188	4‑Methylthiodimethamphetamine (4‑MTDMA)	0.75	250.0	0.75
189	4‑Methylthioethylamphetamine (4‑MTEA)	0.75	250.0	0.75
190	3‑Methylthiofentanyl	0.005	2.5	0.005
191	4‑Methylthiomethamphetamine (4‑MTMA)	0.75	250.0	0.75
192	4‑Methylthiopropylamphetamine (4‑MTPA)	0.75	250.0	0.75
193	Methyprylon	50.0	50.0
194	Metopon	2.0	250.0	2.0
195	Monoacetylmorphines	2.0	250.0	2.0
196	Moramide	2.0	250.0	2.0
197	Morphan, but not including dextrorphan	2.0	250.0	2.0
198	Morpheridine	2.0	250.0	2.0
199	Morphine	1.5	250.0	1.5
200	Morphine‑N‑oxide	2.0	250.0	2.0
201	Myrophine	20.0	20.0
202	Nicocodine	2.0	250.0	2.0
203	Nicodicodine	2.0	250.0	2.0
204	Nicomorphine	2.0	250.0	2.0
205	Noracymethadol	2.0	250.0	2.0
206	Norcodeine	2.0	250.0	2.0
207	Norlevorphanol	2.0	250.0	2.0
208	Normethadone	5.0	2,500.0	5.0
209	Normorphine	20.0	20.0
210	Norpipanone	10.0	5,000.0	10.0
211	Opium	20.0	10,000.0	20.0
212	Oripavine	2.0	250.0	2.0
213	Oxycodone	5.0	2,500.0	5.0
214	Oxymorphone	2.0	250.0	2.0
215	para‑Fluorofentanyl	0.005	2.5	0.005
216	Pentazocine	20.0	20.0
217	Pethidine	10.0	5,000.0	10.0
218	Phenadoxone	10.0	5,000.0	10.0
219	Phenampromide	10.0	5,000.0	10.0
220	Phenazocine	1.0	500.0	1.0
221	Phencyclidine	2.0	250.0	2.0
222	Phendimetrazine	5.0	2,500.0	5.0
223	Phenmetrazine	5.0	2,500.0	5.0
224	Phenomorphan	5.0	2,500.0	5.0
225	Phenoperidine	1.0	500.0	1.0
226	Phentermine	5.0	2,500.0	5.0
227	1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)	2.0	250.0	2.0
228	Pholcodine	5.0	2,500.0	5.0
229	Piminodine	10.0	5,000.0	10.0
230	Pipradrol	1.0	500.0	1.0
231	Piritramide	1.0	500.0	1.0
232	Proheptazine	1.0	500.0	1.0
233	Properidine	25.0	12,500.0	25.0
234	Propiram	10.0	5,000.0	10.0
235	Psilocine	2.0	1,000.0	2.0
236	Psilocybine	2.0	1,000.0	2.0
237	Pyrovalerone	0.75	250.0	0.75
238	Tetrahydrocannabinols (THC)	5.0	1,000.0	2.0
239	Thebacon	2.0	250.0	2.0
240	Thebaine	2.0	250.0	2.0
241	Thiofentanyl	0.005	2.5	0.005
242	2,4,5‑Trimethoxyphenethylamine (2C‑O)	0.5	100.0	0.5
243	Trimeperidine	10.0	5,000.0	10.0
244	2,3,4‑Trimethoxyamphetamine	0.75	250.0	0.75
245	2,3,5‑Trimethoxyamphetamine	0.75	250.0	0.75
246	2,3,6‑Trimethoxyamphetamine	0.75	250.0	0.75
247	2,4,5‑Trimethoxyamphetamine	0.75	250.0	0.75
248	2,4,6‑Trimethoxyamphetamine	0.75	250.0	0.75
249	3,4,5‑Trimethoxyamphetamine	0.75	250.0	0.75

Note: A drug analogue of a drug listed in column 1 of the table is a controlled drug: see paragraph 301.1(b) of the Code.

Schedule 4Border controlled drugs

Note: See regulation 5D.

Border controlled drugs and quantities
Item	Column 1	Column 2	Column 3
Border controlled drug	Commercial quantity (kilograms)	Marketable quantity (grams)
1	Acetorphine	2.0	2.0
2	Acetyl‑alpha‑methylfentanyl	0.005	0.005
3	Acetylcodeine	2.0	2.0
4	Acetyldihydrocodeine	2.0	2.0
5	Acetylmethadol	2.0	2.0
6	Allylprodine	2.0	2.0
7	Alphacetylmethadol	10.0	10.0
8	Alphameprodine	0.2	0.2
9	Alphamethadol	0.2	0.2
10	alpha‑Methylfentanyl	0.005	0.005
11	alpha‑Methylthiofentanyl	0.005	0.005
12	Alphaprodine	25.0	25.0
13	Amphecloral	2.0	2.0
14	3‑(2‑Aminopropyl)indole (alpha‑methyltryptamine (AMT))	2.0	2.0
15	5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)	0.75	0.5
16	Amphetamine	0.75	2.0
17	Anileridine	25.0	25.0
18	Barbiturates	5.0	50.0
19	Benzethidine	10.0	10.0
20	1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)	0.75	0.5
21	Benzoylecgonine	2.0	2.0
22	Benzylmorphine	5.0	5.0
23	Benzylpiperazine	0.75	2.0
24	Betacetylmethadol	5.0	5.0
25	beta‑Hydroxyfentanyl	0.005	0.005
26	beta‑Hydroxy‑3‑methylfentanyl	0.005	0.005
27	beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone)	0.75	2.0
28	Betameprodine	5.0	5.0
29	Betamethadol	5.0	5.0
30	Betaprodine	5.0	5.0
31	Bezitramide	5.0	5.0
32	4‑Bromo‑2,5‑dimethoxyamphetamine	0.5	0.5
32A	2‑(4‑bromo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑B‑NBOMe)	0.002	0.002
33	Bufotenine	2.0	2.0
34	Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant)	2.0	2.0
35	Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)	100.0	25,000.0
36	Cannabis resin	50.0	20.0
37	Cathinone	0.75	2.0
38	1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C)	0.5	0.5
38A	2‑(4‑chloro‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑C‑NBOMe)	0.002	0.002
39	Chlorphentermine	2.0	2.0
40	Clonitazene	5.0	5.0
41	Cocaine	2.0	2.0
42	Codeine	10.0	10.0
43	Codeine‑N‑oxide	10.0	10.0
44	Codoxime	10.0	10.0
45	Desomorphine	2.0	2.0
46	Dexamphetamine	2.0	2.0
47	Dextromoramide	2.0	2.0
48	Diampromide	5.0	5.0
49	Diethylpropion (N, N‑Diethylcathinone)	5.0	5.0
50	Diethylthiambutene	5.0	5.0
51	N,N‑Diethyltryptamine	2.0	2.0
52	Difenoxin	2.0	2.0
53	Dihydrocodeine	10.0	10.0
54	Dihydromorphine	10.0	10.0
55	Dimenoxadol	10.0	10.0
56	Dimepheptanol	10.0	10.0
57	2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)	0.5	0.5
58	2,5‑Dimethoxy‑4‑(n)‑butylthiophenethylamine (2C‑T‑9)	0.5	0.5
59	2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)	0.5	0.5
60	2,5‑Dimethoxy‑4‑ethylthiophenethylamine (2C‑T‑2)	0.5	0.5
61	2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)	0.5	0.5
62	2,5‑Dimethoxy‑4‑(β‑isobutylthio)phenethylamine (2C‑T‑17)	0.5	0.5
63	2,5‑Dimethoxy‑4‑isopropylthiophenethylamine (2C‑T‑4)	0.5	0.5
64	2,5‑Dimethoxy‑4‑(β‑methoxyethylthio)phenethylamine (2C‑T‑13)	0.5	0.5
65	2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)	0.75	2.0
66	2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)	0.5	0.5
67	2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)	0.5	0.5
68	2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)	0.5	0.5
69	2,5‑Dimethoxy‑4‑n‑propylthiophenethylamine (2C‑T‑7)	0.5	0.5
69A	2‑(2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑H‑NBOMe)	0.002	0.002
70	1‑Dimethylamino‑1,2‑diphenylethane	5.0	5.0
71	1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210)	5.0	2.0
72	Dimethylthiambutene	20.0	20.0
73	N,N‑Dimethyltryptamine	2.0	2.0
74	Dioxaphetyl butyrate	2.0	2.0
75	Diphenoxylate	2.0	2.0
76	Dipipanone	10.0	10.0
77	Drotebanol	2.0	2.0
78	Ecgonine	10.0	10.0
79	Ethchlorvynol	50.0	50.0
80	Ethinamate	50.0	50.0
81	Ethylmethylthiambutene	10.0	10.0
82	Ethylmorphine	2.0	2.0
83	Etonitazene	5.0	5.0
84	Etorphine	5.0	5.0
85	Etoxeridine	5.0	5.0
86	Fentanyl	0.005	0.005
87	4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)	0.5	0.5
88	4‑(2‑Fluoroethylthio)‑2,5‑dimethoxyphenethylamine (2C‑T‑21)	0.5	0.5
89	1‑(5‑fluoropentyl)‑3‑(2‑iodobenzyl)indole (AM‑694)	5.0	2.0
90	Furethidine	1.0	1.0
91	Gammabutyrolactone (GBL)	1.0	2.0
92	Glutethimide	50.0	50.0
93	Harmaline	5.0	2.0
94	Harmine	5.0	2.0
95	Heroin (diacetylmorphine)	1.5	2.0
96	Hydrocodone	2.0	2.0
97	Hydromorphinol	2.0	2.0
98	Hydromorphone	2.0	2.0
99	Hydroxyamphetamine	2.0	2.0
100	4‑Hydroxybutanoic acid (GHB)	1.0	2.0
101	2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑(2‑methyloctan‑2‑yl)phenol (CP 47,497)	5.0	2.0
102	2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑(2‑methylnonan‑2‑yl)phenol (CP 47,497‑C8)	5.0	2.0
103	Hydroxypethidine	5.0	5.0
103A	2‑(4‑iodo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑I‑NBOMe)	0.002	0.002
104	Isomethadone	2.0	2.0
105	4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)	0.5	0.5
106	Ketamine	1.0	3.0
107	Ketobemidone	2.0	2.0
108	Levophenacylmorphan	2.0	2.0
109	Levomethorphan	2.0	2.0
110	Levorphanol, but not including dextrorphan	1.0	1.0
111	Lysergamide	0.01	0.1
112	Lysergide (LSD)	0.002	0.002
113	Meprobamate	50.0	50.0
114	Mescaline	7.5	7.5
115	Metazocine	7.0	7.0
116	Methadone	2.0	2.0
117	Methamphetamine	0.75	2.0
118	Methaqualone	5.0	50.0
119	Methcathinone	0.75	2.0
120	Methorphan, but not including dextromethorphan	2.0	2.0
121	5‑Methoxy‑alpha‑methyltryptamine (5‑MeO‑AMT)	2.0	2.0
122	5‑Methoxy‑N,N‑diisopropyltryptamine (5‑MeO‑DiPT)	2.0	2.0
123	4‑Methoxyamphetamine	0.75	2.0
124	4‑Methoxymethamphetamine	0.75	2.0
125	4‑Methylamphetamine	0.75	2.0
126	3,4‑Methylenedioxyamphetamine (MDA)	0.75	0.5
127	2‑(2‑Methoxyphenyl)‑1‑(1‑pentylindol‑3‑yl)ethanone (JWH‑250)	5.0	2.0
128	3,4‑Methylenedioxymethamphetamine (MDMA)	0.5	0.5
129	Methyldesorphine	2.0	2.0
130	Methyldihydromorphine	2.0	2.0
131	3,4‑Methylenedioxypyrovalerone (MDPV)	0.75	2.0
132	3‑Methylfentanyl	0.005	0.005
133	4‑Methylmethamphetamine	0.75	2.0
134	4‑Methylmethcathinone (4‑MMC)	0.75	2.0
135	Methylphenidate	2.0	2.0
136	1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)	2.0	2.0
137	4‑Methylthio‑2,5‑dimethoxyphenethylamine (2C‑T)	0.5	0.5
138	4‑Methylthioamphetamine (4‑MTA)	0.75	2.0
139	4‑Methylthiobutylamphetamine (4‑MTBA)	0.75	2.0
140	4‑Methylthiodimethamphetamine (4‑MTDMA)	0.75	2.0
141	4‑Methylthioethylamphetamine (4‑MTEA)	0.75	2.0
142	3‑Methylthiofentanyl	0.005	0.005
143	4‑Methylthiomethamphetamine (4‑MTMA)	0.75	2.0
144	4‑Methylthiopropylamphetamine (4‑MTPA)	0.75	2.0
145	Methyprylon	50.0	50.0
146	Metopon	2.0	2.0
147	Monoacetylmorphines	2.0	2.0
148	Moramide	2.0	2.0
149	Morphan, but not including dextrorphan	2.0	2.0
150	Morpheridine	2.0	2.0
151	Morphine	1.5	2.0
152	Morphine‑N‑oxide	2.0	2.0
153	(1‑(2‑Morpholin‑4‑ylethyl)indol‑3‑yl)‑napthalen‑1‑ylmethanone (JWH‑200)

5.0	2.0
154	Myrophine	20.0	20.0
155	Napthalen‑1‑yl‑(1‑butylindol‑3‑yl)methanone (JWH‑073)	5.0	2.0
156	Nicocodine	2.0	2.0
157	Nicodicodine	2.0	2.0
158	Nicomorphine	2.0	2.0
159	Noracymethadol	2.0	2.0
160	Norcodeine	2.0	2.0
161	Norlevorphanol	2.0	2.0
162	Normethadone	5.0	5.0
163	Normorphine	20.0	20.0
164	Norpipanone	10.0	10.0
165	Opium	20.0	20.0
166	Oripavine	2.0	2.0
167	Oxycodone	5.0	5.0
168	Oxymorphone	2.0	2.0
169	para‑Fluorofentanyl	0.005	0.005
170	Pentazocine	20.0	20.0
171	1‑Pentyl‑3‑(1‑napthoyl)indol (JWH‑018)	5.0	2.0
172	Pethidine	10.0	10.0
173	1‑Pentyl‑3‑(4‑methyl‑1‑napthoyl)indole (JWH‑122)	5.0	2.0
174	Phenadoxone	10.0	10.0
175	Phenampromide	10.0	10.0
176	Phenazocine	1.0	1.0
177	Phencyclidine	2.0	2.0
178	Phendimetrazine	5.0	5.0
179	Phenmetrazine	5.0	5.0
180	Phenomorphan	5.0	5.0
181	Phenoperidine	1.0	1.0
182	Phentermine	5.0	5.0
183	1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)	2.0	2.0
184	Pholcodine	5.0	5.0
185	Piminodine	10.0	10.0
186	Pipradrol	1.0	1.0
187	Piritramide	1.0	1.0
188	Proheptazine	1.0	1.0
189	Properidine	25.0	25.0
190	Propiram	10.0	10.0
191	Psilocine	0.1	0.1
192	Psilocybine	0.1	0.1
193	Pyrovalerone	0.75	2.0
194	Tetrahydrocannabinols (THC)	5.0	2.0
195	Thebacon	2.0	2.0
196	Thebaine	2.0	2.0
197	Thiofentanyl	0.005	0.005
198	2,4,5‑Trimethoxyphenethylamine (2C‑O)	0.5	0.5
199	Trimeperidine	10.0	10.0
200	2,3,4‑Trimethoxyamphetamine	0.75	2.0
201	2,3,5‑Trimethoxyamphetamine	0.75	2.0
202	2,3,6‑Trimethoxyamphetamine	0.75	2.0
203	2,4,5‑Trimethoxyamphetamine	0.75	2.0
204	2,4,6‑Trimethoxyamphetamine	0.75	2.0
205	3,4,5‑Trimethoxyamphetamine	0.75	2.0

Note: A drug analogue of a drug listed in column 1 of the table is a border controlled drug: see paragraph 301.4(b) of the Code.

Endnotes

Endnote 1About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.

Endnote 2Abbreviation key

ad = added or inserted	o = order(s)
am = amended	Ord = Ordinance
amdt = amendment	orig = original
c = clause(s)	par = paragraph(s)/subparagraph(s)
C[x] = Compilation No. x	/sub‑subparagraph(s)
Ch = Chapter(s)	pres = present
def = definition(s)	prev = previous
Dict = Dictionary	(prev…) = previously
disallowed = disallowed by Parliament	Pt = Part(s)
Div = Division(s)	r = regulation(s)/rule(s)
ed = editorial change	reloc = relocated
exp = expires/expired or ceases/ceased to have	renum = renumbered
effect	rep = repealed
F = Federal Register of Legislation	rs = repealed and substituted
gaz = gazette	s = section(s)/subsection(s)
LA = Legislation Act 2003	Sch = Schedule(s)
LIA = Legislative Instruments Act 2003	Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given	SLI = Select Legislative Instrument
effect	SR = Statutory Rules
(md not incorp) = misdescribed amendment	Sub‑Ch = Sub‑Chapter(s)
cannot be given effect	SubPt = Subpart(s)
mod = modified/modification	underlining = whole or part not
No. = Number(s)	commenced or to be commenced

Endnote 3Legislation history

Number and year	Registration	Commencement	Application, saving and transitional provisions
67, 2002	12 Apr 2002	12 Apr 2002
248, 2002	21 Oct 2002	21 Oct 2002	—
249, 2002	21 Oct 2002	21 Oct 2002(r 2)	—
250, 2002	27 Oct 2002	27 Oct 2002	—
269, 2002	14 Nov 2002	14 Nov 2002	—
270, 2002	14 Nov 2002	14 Nov 2002	—
271, 2002	14 Nov 2002	14 Nov 2002	—
272, 2002	14 Nov 2002	14 Nov 2002	—
30, 2003	7 Mar 2003	7 Mar 2003	—
43, 2003	27 Mar 2003	27 Mar 2003	—
59, 2003	11 Apr 2003	11 April 2003	—
60, 2003	11 Apr 2003	11 April 2003	—
61, 2003	11 Apr 2003	11 April 2003	—
62, 2003	11 Apr 2003	11 April 2003	—
63, 2003	11 Apr 2003	11 April 2003	—
64, 2003	11 Apr 2003	11 April 2003	—
184, 2003	18 July 2003	5 June 2003	—
285, 2003	9 Nov 2003	9 Nov 2003	—
83, 2004	3 May 2004	3 May 2004	—
283, 2004	1 Sept 2004	1 Sept 2004	—
284, 2004	1 Sept 2004	1 Sept 2004	—
311, 2004	5 Nov 2004	5 Nov 2004	—
312, 2004	5 Nov 2004	5 Nov 2004	—
313, 2004	5 Nov 2004	5 Nov 2004	—
314, 2004	5 Nov 2004	5 Nov 2004	—
23, 2005	1 Mar 2005 (F2005L00384)	2 Mar 2005	—
36, 2005	23 Mar 2005 (F2005L00699)	27 Mar 2005	—
57, 2005	8 Apr 2005 (F2005L00703)	11 Apr 2005	—
58, 2005	8 Apr 2005 (F2005L00702)	11 Apr 2005	—
59, 2005	8 Apr 2005 (F2005L00707)	11 Apr 2005	—
60, 2005	8 Apr 2005 (F2005L00701)	11 Apr 2005	—
61, 2005	8 Apr 2005 (F2005L00706)	11 Apr 2005	—
62, 2005	8 Apr 2005 (F2005L00850)	11 Apr 2005	—
85, 2005	26 May 2005 (F2005L01201)	5 June 2005	—
86, 2005	26 May 2005 (F2005L01202)	5 June 2005	—
287, 2005	26 May 2005 (F2005L01203)	5 June 2005	—
88, 2005	26 May 2005 (F2005L01204)	5 June 2005	—
214, 2005	6 Oct 2005 (F2005L02976)	7 Oct 2005	—
298, 2005	16 Dec 2005 (F2005L04036)	17 Dec 2005	—
178, 2006	14 July 2006 (F2006L01551)	15 July 2006	—
220, 2006	25 Aug 2006 (F2006L02639)	26 Aug 2006	—
221, 2006	25 Aug 2006 (F2006L02640)	26 Aug 2006	—
276, 2006	2 Nov 2006 (F2006L03473)	3 Nov 2006	—
277, 2006	2 Nov 2006 (F2006L03474)	3 Nov 2006	—
278, 2006	2 Nov 2006 (F2006L03475)	3 Nov 2006	—
279, 2006	2 Nov 2006 (F2006L03476)	3 Nov 2006	—
280, 2006	2 Nov 2006 (F2006L03538)	3 Nov 2006	—
3, 2007	16 Feb 2007 (F2007L00284)	17 Feb 2007	—
39, 2007	23 Mar 2007 (F2007L00577)	24 Mar 2007	—
47, 2007	30 Mar 2007 (F2007L00847)	31 Mar 2007	—
48, 2007	30 Mar 2007 (F2007L00850)	31 Mar 2007	—
49, 2007	30 Mar 2007 (F2007L00713)	31 Mar 2007	—
50, 2007	30 Mar 2007 (F2007L00851)	31 Mar 2007	—
51, 2007	30 Mar 2007 (F2007L00848)	31 Mar 2007	—
52, 2007	30 Mar 2007 (F2007L00712)	31 Mar 2007	—
125, 2007	24 May 2007 (F2007L01465)	25 May 2007	—
265, 2007	7 Sept 2007 (F2007L03535)	8 Sept 2007	—
266, 2007	7 Sept 2007 (F2007L03537)	8 Sept 2007	—
267, 2007	7 Sept 2007 (F2007L03536)	8 Sept 2007	—
290, 2007	27 Sept 2007 (F2007L03752)	28 Sept 2007	—
160, 2008	8 Aug 2008 (F2008L02843)	9 Aug 2008	—
161, 2008	8 Aug 2008 (F2008L02845)	9 Aug 2008	—
162, 2008	8 Aug 2008 (F2008L02844)	9 Aug 2008	—
218, 2008	31 Oct 2008 (F2008L03611)	1 Nov 2008	—
219, 2008	31 Oct 2008 (F2008L03612)	1 Nov 2008	—
220, 2008	31 Oct 2008 (F2008L03610)	1 Nov 2008	—
34, 2009	13 Mar 2009 (F2009L00835)	14 Mar 2009	—
35, 2009	13 Mar 2009 (F2009L00834)	14 Mar 2009	—
36, 2009	13 Mar 2009 (F2009L00838)	14 Mar 2009	—
37, 2009	13 Mar 2009 (F2009L00837)	14 Mar 2009	—
38, 2009	13 Mar 2009 (F2009L00836)	14 Mar 2009	—
39, 2009	13 Mar 2009 (F2009L00833)	14 Mar 2009	—
77, 2009	15 May 2009 (F2009L01297)	16 May 2009	—
124, 2009	25 June 2009 (F2009L02476)	never commenced (SLI No 176, 2009)	—
125, 2009	25 June 2009 (F2009L02471)	never commenced (SLI No 176, 2009)	—
126, 2009	25 June 2009 (F2009L02477)	never commenced (SLI No 176, 2009)	—
127, 2009	25 June 2009 (F2009L02478)	never commenced (SLI No 176, 2009)	—
208, 2009	21 Aug 2009 (F2009L03208)	22 Aug 2009	—
212, 2009	7 Sept 2009 (F2009L03396)	8 Sept 2009	—
213, 2009	7 Sept 2009 (F2009L03397)	8 Sept 2009	—
214, 2009	7 Sept 2009 (F2009L03398)	8 Sept 2009	—
215, 2009	7 Sept 2009 (F2009L03399)	8 Sept 2009	—
219, 2010	21 July 2010 (F2010L02093)	22 July 2010	—
220, 2010	21 July 2010 (F2010L02094)	22 July 2010	—
221, 2010	21 July 2010 (F2010L02095)	22 July 2010	—
222, 2010	21 July 2010 (F2010L02096)	27 Nov 2010 (r 2)	—
252, 2010	28 Oct 2010 (F2010L02825)	29 Oct 2010	—
253, 2010	28 Oct 2010 (F2010L02826)	29 Oct 2010	—
254, 2010	28 Oct 2010 (F2010L02828)	29 Oct 2010	—
45, 2011	8 Apr 2011 (F2011L00586)	9 Apr 2011	—
22, 2012	9 Mar 2012 (F2012L00553)	10 Mar 2012	—
23, 2012	9 Mar 2012 (F2012L00554)	10 Mar 2012	—
24, 2012	9 Mar 2012 (F2012L00555)	10 Mar 2012	—
25, 2012	9 Mar 2012 (F2012L00556)	10 Mar 2012	—
40, 2012	5 Apr 2012 (F2012L00796)	9 Apr 2012	—
59, 2012	11 May 2012 (F2012L01016)	12 May 2012	—
191, 2012	17 Aug 2012 (F2012L01693)	18 Aug 2012	—
192, 2012	17 Aug 2012 (F2012L01694)	18 Aug 2012	—
193, 2012	17 Aug 2012 (F2012L01695)	18 Aug 2012	—
194, 2012	17 Aug 2012 (F2012L01696)	18 Aug 2012	—
195, 2012	17 Aug 2012 (F2012L01697)	18 Aug 2012	—
66, 2013	23 May 2013 (F2013L00825)	28 May 2013 (s 2)	—
160, 2013	11 July 2013 (F2013L01353)	12 July 2013 (s 2)	—
161, 2013	11 July 2013 (F2013L01357)	12 July 2013 (s 2)	—
162, 2013	11 July 2013 (F2013L01358)	12 July 2013 (s 2)	—
163, 2013	11 July 2013 (F2013L01354)	12 July 2013 (s 2)	—
164, 2013	11 July 2013 (F2013L01356)	12 July 2013 (s 2)	—
165, 2013	11 July 2013 (F2013L01355)	12 July 2013 (s 2)	—
241, 2013	25 Nov 2013 (F2013L01969)	26 Nov 2013 (s 2)	—
47, 2014	16 May 2014 (F2014L00550)	17 May 2014 (s 2)	—
117, 2014	5 Aug 2014 (F2014L01073)	6 Aug 2014 (s 2)	—
6, 2015	2 Mar 2015 (F2015L00234)	3 Mar 2015 (s 2)	—
7, 2015	2 Mar 2015 (F2015L00235)	3 Mar 2015 (s 2)	—
8, 2015	2 Mar 2015 (F2015L00233)	3 Mar 2015 (s 2)	—
9, 2015	2 Mar 2015 (F2015L00236)	3 Mar 2015 (s 2)	—
57, 2015	1 May 2015 (F2015L00621)	2 May 2015 (s 2)	—
126, 2015	10 Aug 2015 (F2015L01237)	11 Aug 2015 (s 2(1) item 1)	—
127, 2015	10 Aug 2015 (F2015L01238)	11 Aug 2015 (s 2(1) item 1)	—
128, 2015	10 Aug 2015 (F2015L01236)	11 Aug 2015 (s 2(1) item 1)	—
129, 2015	10 Aug 2015 (F2015L01235)	11 Aug 2015 (s 2(1) item 1)	—
130, 2015	10 Aug 2015 (F2015L01239)	11 Aug 2015 (s 2(1) item 1)	—
250, 2015	14 Dec 2015 (F2015L01993)	15 Dec 2015 (s 2(1) item 1)	—

Name	Registration	Commencement	Application, saving and transitional provisions
Criminal Code Amendment (Control Orders—Legal Representation for Young People) Regulations 2017	30 June 2017 (F2017L00843)	1 July 2017 (s 2(1) item 1)	—
Criminal Code Amendment (High Risk Terrorist Offenders) Regulations 2017	17 Nov 2017 (F2017L01490)	18 Nov 2017 (s 2(1) item 1)	—

Endnote 4Amendment history

Provision affected	How affected
Part 1
Part 1 heading...................................	ad No 248, 2002
r 2....................................................	rep LA s 48D
r 3....................................................	am No 265, 2007; No 250, 2015; F2017L00843
Part 2
Part 2...............................................	ad No 248, 2002
Division 1
Division 1.........................................	ad F2017L00843
r 3A.................................................	ad F2017L00843
r 3B.................................................	ad F2017L00843
r 3C.................................................	ad F2017L00843
Division 2
Division 2 heading.............................	ad F2017L00843
r 4....................................................	ad No 248, 2002
rs No 184, 2003
am No 285, 2003; No 85, 2005; No 86, 2005; No 87, 2005; No 88, 2005
rep No 298, 2005
ad No 178, 2006
am No 280, 2006
r 4A.................................................	ad No 283, 2004
rs No 220, 2006; No 160, 2008; No 219, 2010
rep No 161, 2013
ad F2017L01490
r 4B.................................................	ad No 284, 2004
rs No 221, 2006; No 161, 2008; No 220, 2010
rep No 165, 2013
ad F2017L01490
r 4C.................................................	ad No 311, 2004
rs No 276, 2006; No 218, 2008; No 253, 2010
rep No 160, 2013
r 4D.................................................	ad No 312, 2004
rs No 277, 2006; No 220, 2008; No 252, 2010
rep No 164, 2013
r 4E..................................................	ad No 313, 2004
rs No 278, 2006
rep No 191, 2012
r 4F..................................................	ad No 314, 2004
rs No 279, 2006; No 162, 2008; No 221, 2010
rep No 163, 2013
r 4G.................................................	ad No 23, 2005
rs No 3, 2007; No 219, 2008; No 254, 2010
rep No 162, 2013
r 4H.................................................	ad No 36, 2005
rs No 39, 2007; No 34, 2009; No 22, 2012
rep No 6, 2015
r 4I...................................................	ad No 60, 2005
rs No 47, 2007; No 35, 2009
rep No 191, 2012
r 4J..................................................	ad No 58, 2005
rs No 48, 2007; No 39, 2009; No 23, 2012
rep No 7, 2015
r 4K.................................................	ad No 57, 2005
rs No 52, 2007; No 36, 2009; No 24, 2012
rep No 8, 2015
r 4L..................................................	ad No 61, 2005
rs No 49, 2007; No 38, 2009; No 25, 2012
rep No 9, 2015
r 4M.................................................	ad No 59, 2005
rs No 50, 2007
rep No 191, 2012
r 4N.................................................	ad No 62, 2005
rs No 51, 2007; No 37, 2009
rep No 191, 2012
r 4P..................................................	ad No 88, 2005
rep No 214, 2005
r 4Q.................................................	ad No 85, 2005
rs No 125, 2007; No 77, 2009; No 59, 2012
rep No 57, 2015
r 4R.................................................	ad No 86, 2005
rep No 214, 2005
r 4S..................................................	ad No 87, 2005
rep No 214, 2005
r 4T..................................................	ad No 214, 2005
rs No 265, 2007; No 212, 2009; No 194, 2012
rep No 130, 2015
r 4U.................................................	adNo 214, 2005
rs No 266, 2007; No 213, 2009; No 191, 2012
rep No 128, 2015
r 4V.................................................	ad No 214, 2005
rs No 267, 2007; No 214, 2009; 2012 No 192, 2012
rep No 127, 2015
r 4W................................................	ad No 298, 2005
rs No 290, 2007; No 215, 2009; No 195, 2012 rep No 126, 2015
r 4X.................................................	ad No 208, 2009
rs No 193, 2012
rep No 129, 2015
r 4Y.................................................	ad No 222, 2010
rep No 241, 2013
Part 3
Part 3 heading...................................	rs No 66, 2013
Division 3.1 heading..........................	ad No 66, 2013
rs and renum F2017L00843
Division 1
Division 1 heading (prev Division 3.1 heading)
Part 3...............................................	ad No 30, 2003
r 5AA...............................................	ad No 45, 2011
rep No 40, 2012
r 5AB...............................................	ad No 45, 2011
rep No 40, 2012
r 5AC...............................................	ad No 45, 2011
rep No 40, 2012
r 5....................................................	ad No 30, 2003
Division 3.2......................................	ad No 66, 2013
Division 3.2 heading..........................	rs and renum F2017L00843
Division 2
Division 2 heading (prev Division 3.2 heading)
r. 5A................................................	ad No 66, 2013
r. 5B.................................................	ad No 66, 2013
r. 5C.................................................	ad No 66, 2013
r. 5D................................................	ad No 66, 2013
r. 5E.................................................	ad No 66, 2013
r. 5F.................................................	ad No 66, 2013
Division 3.3......................................	ad No 250, 2015
Division 3.3 heading..........................	rs and renum F2017L00843
Division 3
Division 3 heading (prev Division 3.3 heading)
r 5G.................................................	ad No 250, 2015
r 5H.................................................	ad No 250, 2015
Part 4
Part 3 heading...................................	ad No 248, 2002
Part 4 heading (prev Part 3)................	renum No 30, 2003
r 5 (prev r 4)......................................	renum No 248,2002
r 6 (prev r 5)......................................	renum No 30, 2008
Part 5
Part 5...............................................	ad F2017L00843
r 7....................................................	ad F2017L00843
Schedule 1
Schedule 1........................................	ad 2002 No 248
am No 249, 2002; No 250, 2002; No 269, 2002; No 270, 2002; No 271, 2002; No 272, 2002; No 43, 2003; No 59, 2003; No 60, 2003; No 61, 2003; No 62, 2003; No 63, 2003; No 64, 2003; No 83, 2004; No 283, 2004; No 284, 2004; No 311, 2004; No 312, 2004; No 313, 2004; No 314, 2004; No 36, 2005; No 57, 2005; No 58, 2005; No 59, 2005; No 60, 2005; No 61, 2005; No 62, 2005
rep No 88, 2005
ad No 178, 2006
am No 280, 2006
Schedule 1A heading.........................	rs No 285, 2003
rep No 298, 2005
ad No 45, 2011
rep No 40, 2012
Schedule 1A.....................................	ad No 184, 2003
rep No 298, 2005
ad No 45, 2011
rep No 40, 2012
Part 1 heading...................................	ad No 285, 2003
rep No 85, 2005
ad No 45, 2011
rep No 40, 2012
Part 1...............................................	rep No 85, 2005
ad No 45, 2011
rep No 40, 2012
Part 2...............................................	ad No 285, 2003
rep No 86, 2005
ad No 45, 2011
rep No 40, 2012
Part 3...............................................	ad No 285, 2003
rep No 87, 2005
ad No 45, 2011
rep No 40, 2012
Part 4...............................................	ad No 45, 2011
rep No 40, 2012
Schedule 2
Schedule 2........................................	ad No 30, 2003
Schedule 3
Schedule 3........................................	ad No 66, 2013
am No 62, 2014
Schedule 4
Schedule 4........................................	ad No 66, 2013
am No 47, 2014